Ono Pharmaceutical Co., Ltd.

OPHLY · OTC
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income$0$18-$7$15
Dep. & Amort.$0$9$9$9
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC$0-$0$0$0
Other Non-Cash$0-$27$37-$24
Operating Cash Flow$0$3$39$0
Investing Activities
PP&E Inv.-$0-$2-$1-$1
Net Acquisitions$0$0$0$0
Inv. Purchases-$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$0$2$17$1
Investing Cash Flow$0-$0$15$0
Financing Activities
Debt Repay.-$0-$8-$8-$0
Stock Issued$0$0$0$0
Stock Repurch.-$0$0$0-$0
Dividends Paid-$0-$17-$1-$18
Other Fin. Act.-$0$26-$0$18
Financing Cash Flow-$0-$0-$9-$0
Forex Effect-$0$0-$1-$0
Net Chg. in Cash$0-$0$44-$0
Supplemental Information
Beg. Cash$1$1$161$1
End Cash$1$1$205$1
Free Cash Flow$0$1$38$0
Ono Pharmaceutical Co., Ltd. (OPHLY) Financial Statements & Key Stats | AlphaPilot